TABLE 2.
Common genes from Venn diagram analysis of HT-29 cells cochallenged with poly(I·C) only versus poly(I·C) plus PC in descending order of Δ fold change of attenuationa
Immune gene protein | Function | Immune pathway(s) | Fold change on challenge withb,c: |
Δ fold change of attenuationc,d | |
---|---|---|---|---|---|
Poly(I·C) only | Poly(I·C) + PC | ||||
TNFAIP3 | Component of ubiquitin-editing protein complex that inhibits NF-κB activation | NF-κB signaling, apoptosis | 9.80 ↑ | 2.35 ↑ | 4.17 ↓ |
CXCL10 (chemokine) | Protein with pleiotropic effects, including stimulation of monocytes and natural killer cells and T cell migration | Cytokine-cytokine receptor interaction, chemokine signaling pathway, TLR signaling pathway | 7.41 ↑ | 2.17 ↑ | 3.42 ↓ |
CXCL2 (chemokine) | Protein expressed at sites of inflammation | Cytokine-cytokine receptor interaction, chemokine signaling pathway | 11.02 ↑ | 3.46 ↑ | 3.18 ↓ |
CXCL3 (chemokine) | Protein with chemotactic activity for neutrophils | Cytokine-cytokine receptor interaction, chemokine signaling pathway | 12.36 ↑ | 3.90 ↑ | 3.17 ↓ |
BCL3 | Contributor to the regulation of transcriptional activation of NF-κB pathway | NF-κB signaling, apoptosis | 10.29 ↑ | 3.33 ↑ | 3.09 ↓ |
CX3CL1 (chemokine) | Protein with chemotactic activity for T cells and monocytes | Cytokine-cytokine receptor interaction, chemokine signaling pathway | 7.20 ↑ | 2.68 ↑ | 2.68 ↓ |
CCL20 (chemokine) | Chemotactic factor that attracts lymphocytes and neutrophils | Cytokine-cytokine receptor interaction, chemokine signaling pathway | 10.55 ↑ | 4.07 ↑ | 2.59 ↓ |
CXCL1 (chemokine) | Protein with chemotactic activity for neutrophils | Cytokine-cytokine receptor interaction, chemokine signaling pathway | 16.31 ↑ | 6.77 ↑ | 2.41 ↓ |
BIRC3 | Inhibitor of apoptosis by binding to TNF receptor-associated factors TRAF1 and TRAF2 (apoptotic suppressor) | Apoptosis | 6.08 ↑ | 2.72 ↑ | 2.24 ↓ |
NFKBIE | Inhibitor of NF-κB by complexing with and trapping it in the cytoplasm | NF-κB signaling | 5.28 ↑ | 2.63 ↑ | 2.00 ↓ |
LIF (cytokine) | Inducer of terminal differentiation in leukemic cells | Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway | 3.17 ↑ | 2.09 ↑ | 1.52 ↓ |
NFKBIA | Inhibitor of NF-κB/REL complexes by trapping REL dimers in the cytoplasm | NF-κB signaling | 5.35 ↑ | 3.90 ↑ | 1.37 ↓ |
IL-8 (chemokine) | Potent chemotactic factor that attracts neutrophils, basophils, and T cells | Cytokine-cytokine receptor interaction, chemokine signaling pathway, TLR signaling pathway | 12.98 ↑ | 9.79 ↑ | 1.33 ↓ |
Immune gene function data are from GeneCards (http://www.genecards.org), and immune pathway data are from KEGG (http://www.genome.jp/kegg/pathway.html).
Fold change or expression ratio = 2log2ratio. ↑, upregulation.
A 2-fold change in differentially expressed genes and a P value of <0.05 were considered statistically significant.
Δ fold change = expression with poly(I·C)/[expression with poly(I·C) + expression with PC]. ↓, a reduction in the Δ fold change of HT-29 cells challenged with poly(I·C).